Clinical trial evaluates synthetic cannabinoid as brain cancer treatment

Clinical trial evaluates synthetic cannabinoid as brain cancer treatment

Existing treatment for brain trauma is being tested in patients with all forms of cancer.

Santosh Kesari, UC San Diego

Researchers at UC San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of

...read more at http://health.universityofcalifornia.edu/2012/09/25/clinical-trial-evaluates-synthetic-cannabinoid-as-brain-cancer-treatment/

by